Scott Allen Armstrong
Affiliations: | Biology, Molecular and Cellular | Harvard University, Cambridge, MA, United States |
Area:
General Biology, Molecular Biology, Biochemistry, OncologyWebsite:
https://hsci.harvard.edu/people/scott-armstrong-md-phdGoogle:
"Scott Allen Armstrong"Bio:
Mean distance: (not calculated yet)
Parents
Sign in to add mentorMichael Stuart Brown | grad student | 1994 | UT Southwestern | |
(Molecular and biochemical characterization of Rab geranylgeranyl transferase.) | ||||
Joseph L. Goldstein | grad student | 1994 | UT Southwestern |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Heikamp EB, Martucci C, Henrich JA, et al. (2024) NUP98 fusion proteins and KMT2A-MENIN antagonize PRC1.1 to drive gene expression in AML. Cell Reports. 43: 114901 |
Kwon MC, Thuring JW, Querolle O, et al. (2024) Preclinical efficacy of potent and selective menin-KMT2A inhibitor JNJ-75276617 in KMT2A- and NPM1-altered leukemias. Blood |
Smolko AE, Sullivan DW, Olsen SN, et al. (2024) A MOZ-TIF2 leukemia mouse model displays KAT6-dependent H3K23 propionylation and overexpression of a set of active developmental genes. Proceedings of the National Academy of Sciences of the United States of America. 121: e2405905121 |
Gu H, Chen C, Hou ZS, et al. (2024) PI3Kγ maintains the self-renewal of acute myeloid leukemia stem cells by regulating the pentose phosphate pathway. Blood |
Tubío-Santamaría N, Jayavelu AK, Schnoeder TM, et al. (2023) Immunoproteasome function maintains oncogenic gene expression in KMT2A-complex driven leukemia. Molecular Cancer. 22: 196 |
Issa GC, Aldoss I, DiPersio J, et al. (2023) The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia. Nature |
Uckelmann HJ, Haarer EL, Takeda R, et al. (2022) Mutant NPM1 directly regulates oncogenic transcription in acute myeloid leukemia. Cancer Discovery |
Soto-Feliciano YM, Sanchez-Rivera FJ, Perner F, et al. (2022) A molecular switch between mammalian MLL complexes dictates response to Menin-MLL inhibition. Cancer Discovery |
Aubrey BJ, Cutler JA, Bourgeois W, et al. (2022) IKAROS and MENIN coordinate therapeutically actionable leukemogenic gene expression in MLL-r acute myeloid leukemia. Nature Cancer |
Heikamp EB, Henrich JA, Perner F, et al. (2021) The Menin-MLL1 interaction is a molecular dependency in NUP98-rearranged AML. Blood |